These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 22612072)
1. Adeno-associated virus-mediated gene delivery of the human ND4 complex I subunit in rabbit eyes. Shi H; Gao J; Pei H; Liu R; Hu WK; Wan X; Li T; Li B Clin Exp Ophthalmol; 2012 Dec; 40(9):888-94. PubMed ID: 22612072 [TBL] [Abstract][Full Text] [Related]
2. Efficiency and safety of AAV-mediated gene delivery of the human ND4 complex I subunit in the mouse visual system. Guy J; Qi X; Koilkonda RD; Arguello T; Chou TH; Ruggeri M; Porciatti V; Lewin AS; Hauswirth WW Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4205-14. PubMed ID: 19387075 [TBL] [Abstract][Full Text] [Related]
3. Mutant NADH dehydrogenase subunit 4 gene delivery to mitochondria by targeting sequence-modified adeno-associated virus induces visual loss and optic atrophy in mice. Yu H; Ozdemir SS; Koilkonda RD; Chou TH; Porciatti V; Chiodo V; Boye SL; Hauswirth WW; Lewin AS; Guy J Mol Vis; 2012; 18():1668-83. PubMed ID: 22773905 [TBL] [Abstract][Full Text] [Related]
4. Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial. Koilkonda RD; Yu H; Chou TH; Feuer WJ; Ruggeri M; Porciatti V; Tse D; Hauswirth WW; Chiodo V; Boye SL; Lewin AS; Neuringer M; Renner L; Guy J JAMA Ophthalmol; 2014 Apr; 132(4):409-20. PubMed ID: 24457989 [TBL] [Abstract][Full Text] [Related]
5. Induction of rapid and highly efficient expression of the human ND4 complex I subunit in the mouse visual system by self-complementary adeno-associated virus. Koilkonda RD; Chou TH; Porciatti V; Hauswirth WW; Guy J Arch Ophthalmol; 2010 Jul; 128(7):876-83. PubMed ID: 20625049 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of rAAV2-ND4 Treatment for Leber's Hereditary Optic Neuropathy. Wan X; Pei H; Zhao MJ; Yang S; Hu WK; He H; Ma SQ; Zhang G; Dong XY; Chen C; Wang DW; Li B Sci Rep; 2016 Feb; 6():21587. PubMed ID: 26892229 [TBL] [Abstract][Full Text] [Related]
7. Immune Response and Intraocular Inflammation in Patients With Leber Hereditary Optic Neuropathy Treated With Intravitreal Injection of Recombinant Adeno-Associated Virus 2 Carrying the ND4 Gene: A Secondary Analysis of a Phase 1/2 Clinical Trial. Bouquet C; Vignal Clermont C; Galy A; Fitoussi S; Blouin L; Munk MR; Valero S; Meunier S; Katz B; Sahel JA; Thomasson N JAMA Ophthalmol; 2019 Apr; 137(4):399-406. PubMed ID: 30730541 [TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy. Yang S; Ma SQ; Wan X; He H; Pei H; Zhao MJ; Chen C; Wang DW; Dong XY; Yuan JJ; Li B EBioMedicine; 2016 Aug; 10():258-68. PubMed ID: 27426279 [TBL] [Abstract][Full Text] [Related]
9. Construction and detection of a novel type of recombinant human rAAV2/2-ND4. Pei H; Wan X; Hu W; Dong X; Li B Eye Sci; 2013 Jun; 28(2):55-9. PubMed ID: 24396955 [TBL] [Abstract][Full Text] [Related]
10. Chemical and material communication between the optic nerves in rats. Yang S; He H; Zhu Y; Wan X; Zhou LF; Wang J; Wang WF; Liu L; Li B Clin Exp Ophthalmol; 2015 Nov; 43(8):742-8. PubMed ID: 25950380 [TBL] [Abstract][Full Text] [Related]
13. Visual Acuity Testing Before and After Intravitreal Injection of rAAV2-ND4 in Patients. Li B; Wu C Methods Mol Biol; 2018; 1715():305-311. PubMed ID: 29188523 [TBL] [Abstract][Full Text] [Related]
14. Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy : preparation for gene therapy clinical trial. Lam BL; Feuer WJ; Schiffman JC; Porciatti V; Vandenbroucke R; Rosa PR; Gregori G; Guy J JAMA Ophthalmol; 2014 Apr; 132(4):428-36. PubMed ID: 24525545 [TBL] [Abstract][Full Text] [Related]
15. Gene delivery to mitochondria by targeting modified adenoassociated virus suppresses Leber's hereditary optic neuropathy in a mouse model. Yu H; Koilkonda RD; Chou TH; Porciatti V; Ozdemir SS; Chiodo V; Boye SL; Boye SE; Hauswirth WW; Lewin AS; Guy J Proc Natl Acad Sci U S A; 2012 May; 109(20):E1238-47. PubMed ID: 22523243 [TBL] [Abstract][Full Text] [Related]
16. In Vivo Fluorescence Retinal Imaging Following AAV2-Mediated Gene Delivery in the Rat Retina. Lee JY; Hwang Y; Kim JH; Kim YS; Jung BK; Kim P; Lee H Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3390-6. PubMed ID: 27367507 [TBL] [Abstract][Full Text] [Related]
18. LHON gene therapy vector prevents visual loss and optic neuropathy induced by G11778A mutant mitochondrial DNA: biodistribution and toxicology profile. Koilkonda R; Yu H; Talla V; Porciatti V; Feuer WJ; Hauswirth WW; Chiodo V; Erger KE; Boye SL; Lewin AS; Conlon TJ; Renner L; Neuringer M; Detrisac C; Guy J Invest Ophthalmol Vis Sci; 2014 Oct; 55(12):7739-53. PubMed ID: 25342621 [TBL] [Abstract][Full Text] [Related]
19. Postsurgical assessment and long-term safety of recombinant adeno-associated virus-mediated gene transfer into the retinas of dogs and primates. Le Meur G; Weber M; Péréon Y; Mendes-Madeira A; Nivard D; Deschamps JY; Moullier P; Rolling F Arch Ophthalmol; 2005 Apr; 123(4):500-6. PubMed ID: 15824224 [TBL] [Abstract][Full Text] [Related]
20. Can an in vivo imaging system be used to determine localization and biodistribution of AAV5-mediated gene expression following subretinal and intravitreal delivery in mice? Ezra-Elia R; Obolensky A; Ejzenberg A; Ross M; Mintz D; Banin E; Ofri R Exp Eye Res; 2018 Nov; 176():227-234. PubMed ID: 30171858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]